Sectors

TCRT
Alaunos Therapeutics, Inc.
1.97
1 x 1.96
1 x 2.04
bid
ask
-
0.12
5.81%
10:35 AM
timesize
Ytd-39.05%
1y-34.16%
1.97
day range
2.05
1.67
52 week range
4.59
Open2.05Prev Close2.09Low1.97High2.05Mkt Cap5.10M
Vol8.58KAvg Vol15.98KEPS-2.17P/E-0.96Forward P/E-3.25
Beta-1.02Short Ratio10.12Inst. Own12.08%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg2.31200-d Avg2.871yr Est1.75
Income Statement
Operating Expenses1.01M
Research and Development Expense427.00K
Selling, General and Administrative Expense585.00K
Operating Income-1.01M
Net Income-1.01M
Net Income Common Stock-1.01M
Net Income Common Stock (USD)-1.01M
Consolidated Income-1.01M
Earnings per Basic Share-0.59
Earnings per Basic Share (USD)-0.59
Earnings per Diluted Share-0.59
Earning Before Interest & Taxes (EBIT)-1.01M
Earning Before Interest & Taxes (USD)-1.01M
Weighted Average Shares1.95M
Weighted Average Shares Diluted1.95M
Balance Sheet
Cash and Equivalents354.00K
Cash and Equivalents (USD)354.00K
Current Assets970.00K
Property, Plant & Equipment Net82.00K
Total Assets1.88M
Current Liabilities595.00K
Total Liabilities595.00K
Accumulated Retained Earnings (Deficit)-925.63M
Shareholders Equity1.29M
Shareholders Equity (USD)1.29M
Assets Non-Current913.00K
Trade and Non-Trade Payables400.00K
Cash Flow
Depreciation, Amortization & Accretion8.00K
Net Cash Flow / Change in Cash & Cash Equivalents-1.03M
Net Cash Flow from Operations-1.03M
Share Based Compensation141.00K